Skip to Main Content

Paper Details

Impact of T-cell immunity on chemotherapy response in childhood acute lymphoblastic leukemia.
Blood
3
2022
ABL1, ABL1 mutations, ALL, Arf, B-cell ALL, BCR, Ph, Ph+ ALL, T, T cells, T-cell, acute lymphoblastic leukemia, childhood acute lymphoblastic leukemia, children, dasatinib, drug-resistant leukemia, interferon, interleukin 12, leukemia, mice, murine, peripheral blood immune cell
Author NameAffiliation
John EastonSt. Jude Children's Research Hospital
John EastonSt. Jude Children's Research Hospital
Cheng ChengSt. Jude Children's Research Hospital
Shawn LeeDivision of Pharmaceutical Sciences, Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital
Shawn LeeYong Loo Lin School of Medicine, National University of Singapore
Ching-Hon PuiSt. Jude Children's Research Hospital
Ching-Hon PuiSt. Jude Children's Research Hospital
  • 1 - 7

Datasets

Release 1.2